IconOVir Bio
Latest round
- Series A
Last raised
- Dec 2020
Total raised
- $77M
Investors
- 8
About IconOVir Bio
IconOVir Bio, Inc.Founded in 2018 and headquartered in San Diego, US, IconOVir Bio, Inc. specializes in creating therapies that target cancer cells using engineered viruses. The company has not undergone significant pivots or changes in its operations. Mark McCamish serves as the CEO.IconOVir specializes in developing innovative therapeutic solutions aimed at curing cancer and enhancing the quality of life for patients globally. The company's core product offerings include advanced biopharmaceuticals designed to target and eliminate cancer cells while minimizing side effects. These therapies utilize technology in oncolytic virotherapy, harnessing engineered viruses to selectively infect and destroy tumor cells. The primary end users of these products are cancer patients, while healthcare providers and oncologists represent the client base administering these therapies.IconOVir generates revenue through direct-to-consumer sales and strategic partnerships with healthcare institutions. The transaction structure includes sales of its biopharmaceutical products to hospitals and clinics, enabling them to offer advanced cancer treatments. Customers engage in bulk purchases and may enter into long-term agreements, facilitating consistent revenue streams. The company aims to design and launch additional therapies targeting specific cancer types over the next few years. Furthermore, plans are in place to enter emerging markets in Asia and parts of Europe by 2023, with a focus on increasing access to their innovative treatments.
Who invested in IconOVir Bio
8 investors across 1 round
See all investors in IconOVir Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 1, 2020
Amount
$77M
Investors
Questions about IconOVir Bio
Who invested in IconOVir Bio?
IconOVir Bio has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has IconOVir Bio raised?
IconOVir Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did IconOVir Bio last raise money?
IconOVir Bio's most recent round on record is a Series A, in Dec 2020.
What does IconOVir Bio do?
IconOVir Bio is a biotechnology company.
Where is IconOVir Bio headquartered?
IconOVir Bio is headquartered in San Diego, US.
Which VCs invest in companies like IconOVir Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at IconOVir Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like IconOVir Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.